FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Objectionable Conditions at Ukraine Clinical Test Site

FDA warns a clinical trial site in Ukraine that it failed to properly maintain required records.

Biologics

Aspen Institute Cell Products Illegal: FDA

FDA cautions Aspen Institute that it is illegally marketing cellular and exosome products to treat diseases and conditions in humans.

Medical Devices

Location Affects FDA Device Inspections: Analysis

Epstein, Becker & Green attorney Bradley Thompson says there are differences between counties in the numbers of medical device inspections.

FDA General

Senate Committee Vote on Califf Nomination Delayed

The Senate Health, Education, Labor & Pensions Committee delays a 1/5-scheduled confirmation vote on FDA commissioner nominee Robert Califf until 1/15...

Medical Devices

FDA Contributed to Covid Test Shortage: Lawyers

Attorneys Jeffrey Gibbs and Gail Javitt say FDA contributed to the shortage of Covid-19 tests and call for a thorough, objective review of FDAs perfor...

Human Drugs

FDA Wants iPLEDGE Web Site Solutions

FDA calls on isotretinoin manufacturers to propose a workable solution to issues with the iPLEDGE REMS Web site and telephone call center so treatment...

Human Drugs

Amcyte Pharma Marketing Illegal Covid Drug: FDA

FDA warns Kirkland, WA-based Amcyte Pharma it is illegally selling Nasitrol, an unapproved and misbranded drug, as a Covid-19 cure.

Human Drugs

Abbvie Gets Breakthrough Status on Lung Cancer Drug

FDA grants AbbVie a breakthrough therapy designation for telisotuzumab vedotin and its use in treating certain patients with advanced/metastatic epide...

Federal Register

Info Collection on Drug Compounding Facilities

Federal Register notice: FDA sends to OMB an information collection extension entitled Obtaining Information To Understand Challenges and Opportunitie...

Medical Devices

Fresenius Connect Infusion Cyber Alert

FDA says the Cybersecurity and Infrastructure Security Agency has identified vulnerabilities in the Fresenius Kabi Agilia Connect Infusion System.